索拉非尼
肝细胞癌
医学
银屑病
内科学
门静脉
胃肠病学
血栓
外科
放射科
皮肤病科
作者
Tamotsu Nakagawa,Seiji Chubachi
出处
期刊:PubMed
日期:2015-09-01
卷期号:42 (9): 1107-9
摘要
A 55-year-old man had been diagnosed with Wilson's disease and was treated with D-penicillamine 36 years earlier. He also had a 20-year history of psoriasis vulgaris and cyclosporine treatment. In 2012, a he presented with a hepatocellular carcinoma(HCC)that was removed via partial hepatic resection. In 2014, multiple HCC and a portal vein tumor thrombus were found in his posterior lobe. Sorafenib treatment was initiated. Cyclosporine treatment was continued. Three months later, abdominal enhanced CT revealed marked tumor reduction and shrinkage of the portal vein tumor thrombus. The therapeutic effect of sorafenib continued for 6 months. We did not observe deterioration in his psoriasis vulgaris and Wilson's disease for 9 months after sorafenib initiation.
科研通智能强力驱动
Strongly Powered by AbleSci AI